Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma

Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma

Objective. Patients with gastroenteropancreatic neuroendocrine carcinoma (NEC) have a poor prognosis. Platinum-based combination chemotherapy is commonly used as first-line treatment; however, the role of salvage chemotherapy remains unknown. This study aimed to analyze the efficacy and safety of a...

Full description

Bibliographic Details
Main Authors: Ando, Takayuki, Hosokawa, Ayumu, Yoshita, Hiroki, Ueda, Akira, Kajiura, Shinya, Mihara, Hiroshi, Nanjo, Sohachi, Fujinami, Haruka, Nishikawa, Jun, Ogawa, Kohei, Nakajima, Takahiko, Imura, Johji, Sugiyama, Toshiro
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493294/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493294/

Similar Items